The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Brilliant update. The threads that George mentioned were so encouraging. Very good
London Medical Labs now have 86 clinics of their own.
No. I think that went to Dragonfly
Its no surprise. It was one of the questions put to Marc. We are still selling. Did, however, sell the plant for the same value as our current market cap. Smart move
https://www.investegate.co.uk/goodbody-health-ltd--gdby-/rns/divestment-of-polish-cbd-operations/202212160700049181J/
Selling up on cbd.....
https://www.bbc.co.uk/news/health-63331805?
at_medium=RSS&at_campaign=KARANGA
He referred to crossing paths soon with the NHS. I have previously posted this link. I think we will play a part in the trials
Apparently, you are right. It is to reduce operating costs. Its not just Marc to go. Others have gone with him
Marc has resigned with immediate effect. Not a good sign at all.
Current assets are £3.9 m. 3 times the current share price
Nothing wrong with the business. Its the share price at £1.3m market cap that is out of sorts. We all know the business is worth much more than that.
No. They will always email shareholders after an announcement. I may have subscribed to this early on. I will pass on anything relevant.
Marc has stated that they don't need money and that they have a war chest to roll out the strategy. The email to investors may tell us more when it lands today.
Goodbody Health turns focus to preventative diagnostics
03:15 Fri 11 Nov 2022
Jai Singh
View
Goodbody Health Ltd
AQSE:GDBY
OTCQB:GDBYF
Goodbody Health Ltd - Goodbody Health turns focus to preventative diagnostics
Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) said its focus is now on preventative diagnostics as it looks to become a “leading aggregator” of innovative technology and tests.
The health diagnostics firm said in a third-quarter trading update that it will focus on blood and genetic testing alongside other services at its 258 clinics, including ear wax removal.
“The range of opportunities to develop our proposition in this exciting growth market to support the NHS and help people have better health outcomes are very exciting,” said chief executive Marc Howells.
“This direction of travel is one we embrace and look forward to delivering in the post-covid UK."
In the nine months to 30 September 2022, the AQSE Growth Market-listed company said revenue fell 6% compared to 2021 to £9.29mln, largely due to reduced but ongoing Covid testing delaying the roll-out of other tests.
Gross profit in the year-to-date also slipped 16% to £4.46mln, “reflecting the competitive environment”, a statement said.
As a result, it said the expected outcome for the end of the year will be lower than anticipated due to the current economic client, a squeeze on consumer spending and lead time for new products.
3rd quarter results are out. We now have 258 clinics and more products on the way. Dip in gross profit as predicted.
Allied have 50+ pharmacies. We are only in 17 at the minute. Same with Superdrug. Lots of scope everywhere....
The share price is effectively at rock bottom. It cannnot get any worse. Unless of course they go bust.
Take heart from the fact that they are signing deals with major players in the market . They have a massive potential market with more products coming online soon and they are expanding all the time with their own money.
One day this share price will explode but it will not be over night. It maybe years before I get my money back, if at all.
Geremy asked the long term holders to hang in there. Long term holders are only too familiar with this sitution. Its rough going but its an exciting business that we are invested in. Enjoy yor day Lebad, things will get better.
That puts the market cap at below £2m now by my reckoning. Share price is out of sink with whats going on in the business.
As hard as it is, we need to keep the faith. I am in exactly the same position as you MPBUK but we now have 200 clinics online with more channels opening up all the time. They will generate £16m again soon enough to replace Covid testing. There will be more deals going on in the background that we do not know about yet.
Anton Kreil explains the 90/90/90 principle very well. We are all suckers to the market. We must wait for the value to build in the business to allow Goodbody to sell. Marc said he has brought 6 companies to a sale position. This one will be no different. We will see our money at the point of sale. There will be lots of prespective buyers if they prove that the model works. Are 3rd quarter results out next week?